Actuate Therapeutics, Inc. (ACTU)
Nasdaq: ACTU · Pharmaceutical Preparations · Fort Worth, TX · filing with the SEC since 2015
Who runs Actuate Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Schmitt Daniel M
President, CEO and Director. First filing Aug 2024, latest Oct 29, 2026, 1 filing in all.
Officers reporting now
3
of 29 people with a filing in the last fifteen months
Directors reporting now
26
39 people on the record since 2024
Officerssales are open-market, Nov 2, 2025 to Nov 2, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Schmitt Daniel M | President, CEO and Director | Aug 2024 | Oct 29, 2026 | none |
| Lytle Paul J | Chief Financial Officer | Aug 2024 | Apr 1, 2026 | none |
| Mazar Andrew Paul | Chief Operating Officer | Aug 2024 | Apr 1, 2026 | none |
Directorssales are open-market, Nov 2, 2025 to Nov 2, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Demetriades James T | director | Nov 2026 | Nov 2, 2026 | none |
| Kairos Spv Fund LLC | director | Aug 2024 | Nov 2, 2026 | none |
| Kairos Venture Investments, LLC | director | Nov 2026 | Nov 2, 2026 | none |
| Kairos Venture Opportunities I, L.P. | director | Aug 2024 | Nov 2, 2026 | none |
| Kairos Venture Partners II, L.P. | director | Aug 2024 | Nov 2, 2026 | none |
| Kairos-Actuate Spv, L.P. | director | Aug 2024 | Nov 2, 2026 | none |
| Thomson Todd S | director | Aug 2024 | Nov 2, 2026 | 1 · $1.6M |
| Bios 2024 Co-Invest, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Actuate Co-Invest I, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Actuate Co-Invest II, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Actuate Co-Invest III, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Clinical Opportunity Fund, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Fund I Qp, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Fund I, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Fund II Nt, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Fund II Qp, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Fund II, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Fund III Nt, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Fund III Qp, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Bios Fund III, LP | director | Aug 2024 | Oct 30, 2026 | none |
| Fletcher Aaron G.L. | director | Aug 2024 | May 22, 2026 | none |
| Huber Martin H. Jr. | director | May 2026 | May 22, 2026 | none |
| Keyes Jason A | director | Aug 2024 | May 22, 2026 | none |
| Ronneberg Amy L | director | Aug 2024 | May 22, 2026 | none |
| Sawhney Roger | director | Aug 2024 | May 22, 2026 | none |
| Zabrowski Dan | director | Aug 2024 | May 22, 2026 | none |
Earlier names on the record10, newest filing first
Bios Advisors Gp, LLC · director · last filing Jun 2025Bios Capital Management, LP · director · last filing Jun 2025Bios Equity Cof, LP · director · last filing Jun 2025Bios Equity Partners II, LP · director · last filing Jun 2025Bios Equity Partners III, LP · director · last filing Jun 2025Bios Equity Partners, LP · director · last filing Jun 2025Bp Directors, LP · director · last filing Jun 2025Cavu Advisors, LLC · director · last filing Jun 2025Cavu Management, LP · director · last filing Jun 2025Kreis Leslie W. · director · last filing Jun 2025
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.